Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells.

BACKGROUND Expression of polo-like kinase-1 (PLK1), which has several functions in mitotic progression, is elevated in a broad range of human tumors. To investigate the role of PLK1 in neoplastic proliferation, we used the technique of RNA interference. METHODS Cells from several different cancer cell lines (MCF-7 breast cancer cells, HeLa S3 cervical cancer cells, SW-480 colon cancer cells, and A549 lung cancer cells) were transfected with small interfering (si) RNAs targeted against the human PLK1 or lamin genes. Northern and western blot analyses were used to examine PLK1 gene expression in transfected cancer cells and normal cells (human mammary epithelial cells [HMECs]). The phenotype, proliferation, and cell cycle distribution of cells transfected with siRNAs were also monitored by fluorescence microscopy and fluorescence-activated cell sorting analysis. RESULTS All cancer cell lines transfected with low doses of siRNAs targeted to PLK1 had greatly decreased levels of PLK1 mRNA and protein. siRNA4, which had the strongest inhibitory effect, reduced PLK1 mRNA in MCF-7 cells by 70% and PLK1 protein in MCF-7 cells by 95% 24 hours after transfection. Cell proliferation was reduced by between 66% and 99% 48 hours after transfection, and apoptosis was increased from 1%-5% to 13%-50% in transfected cells. Transfected SW-480 cells were mitotically arrested, and their centrosomes had lost the ability to nucleate microtubules. HMECs took up siRNAs less efficiently than cancer cells, and transfection with siRNAs targeted to PLK1 did not inhibit their proliferation. CONCLUSIONS PLK1 function appears to be essential for centrosome-mediated microtubule events and, consequently, for spindle assembly. siRNAs targeted against human PLK1 may be valuable tools as antiproliferative agents that display activity against a broad spectrum of neoplastic cells at very low doses.

[1]  E. Nishida,et al.  Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase , 2001, Nature.

[2]  J. Bartek,et al.  Cell cycle analysis and chromosomal localization of human Plk 1 , a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc 5 , 2022 .

[3]  J. Yuan,et al.  Polo-like kinase, a novel marker for cellular proliferation. , 1997, The American journal of pathology.

[4]  K. Strebhardt.  PLK (POLO‐Like Kinase) , 2002 .

[5]  H. Ackermann,et al.  Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer , 1997, Oncogene.

[6]  B. Brinkley,et al.  Managing the centrosome numbers game: from chaos to stability in cancer cell division. , 2001, Trends in cell biology.

[7]  Amy A. Caudy,et al.  Post-transcriptional gene silencing by double-stranded RNA , 2001, Nature Reviews Genetics.

[8]  J. Bisi,et al.  Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[9]  A. Beaudet,et al.  Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity , 1998, Nature Genetics.

[10]  U. Staubli,et al.  The polo‐like protein kinases Fnk and Snk associate with a Ca2+‐ and integrin‐binding protein and are regulated dynamically with synaptic plasticity , 1999, The EMBO journal.

[11]  P. Yaswen,et al.  Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells , 1999, Oncogene.

[12]  J. Bartek,et al.  Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. , 1994, Journal of cell science.

[13]  Kim Nasmyth,et al.  The Polo‐like kinase Cdc5p and the WD‐repeat protein Cdc20p/fizzy are regulators and substrates of the anaphase promoting complex in Saccharomyces cerevisiae , 1998, The EMBO journal.

[14]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[15]  T. Karn,et al.  Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Michael Rowe,et al.  The rest is silence. , 2002, Health affairs.

[17]  H. Lane,et al.  Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes , 1996, The Journal of cell biology.

[18]  H. Kazazian.  Wiley encyclopedia of molecular medicine , 2002 .

[19]  L. Liotta,et al.  Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. , 2001, Cancer research.

[20]  Gunther Hartmann,et al.  Antisense therapy in oncology: new hope for an old idea? , 2001, The Lancet.

[21]  B. Achinstein,et al.  Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. , 2009, Nutrition reviews.

[22]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[23]  P. Sharp,et al.  RNA interference--2001. , 2001, Genes & development.

[24]  J. M. Mullin,et al.  Increased Tight Junction Permeability Can Result from Protein Kinase C Activation/Translocation and Act as a Tumor Promotional Event in Epithelial Cancers , 2000, Annals of the New York Academy of Sciences.

[25]  F. Taieb,et al.  The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes. , 2001, Molecular biology of the cell.

[26]  G. Hannon,et al.  The rest is silence. , 2001, RNA.

[27]  A. Inferrera,et al.  Ultrastructural observations on the microvasculature in advanced gastric carcinomas. , 2001, Histology and histopathology.

[28]  J. Bereiter-Hahn,et al.  Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1 , 2002, Oncogene.

[29]  D. Cerretti,et al.  Cell-Cell Adhesion Mediated by Binding of Membrane-anchored Ligand LERK-2 to the EPH-related Receptor Human Embryonal Kinase 2 Promotes Tyrosine Kinase Activity* , 1996, The Journal of Biological Chemistry.

[30]  D. Glover,et al.  Polo kinase and Asp are needed to promote the mitotic organizing activity of centrosomes , 2001, Nature Cell Biology.

[31]  S. Loibl,et al.  Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells , 2002, Oncogene.

[32]  K. Hunt,et al.  Adenoviral gene therapy. , 2002, The oncologist.

[33]  D. Glover,et al.  Polo-like kinases: a team that plays throughout mitosis. , 1998, Genes & development.

[34]  D. Glover,et al.  The conserved Schizosaccharomyces pombe kinase plo1, required to form a bipolar spindle, the actin ring, and septum, can drive septum formation in G1 and G2 cells. , 1995, Genes & development.

[35]  A. Fire,et al.  Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Osada,et al.  Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines , 2000, Nature Cell Biology.

[37]  S. Doxsey,et al.  Re-evaluating centrosome function , 2001, Nature Reviews Molecular Cell Biology.